Keyword: Paul Campanelli

Endo Pharmaceuticals

10. Paul Campanelli, Endo

U.S. generics pricing pressure is still pulling back Endo's performance, and opioid lawsuits are still hanging over its head. But that didn’t stop CEO Paul Campanelli from snagging a huge pay jump in 2018.

8. Rajiv De Silva

Endo was struggling when CEO Rajiv de Silva departed last September, turning the reins over to current chief Paul Campanelli. But that didn’t stop de Silva from tallying more than $19 million in 2016 pay.